Tradewinds LLC. Trims Stock Holdings in The Cigna Group (NYSE:CI)

Tradewinds LLC. cut its holdings in shares of The Cigna Group (NYSE:CI - Free Report) by 94.2% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 858 shares of the health services provider's stock after selling 13,988 shares during the quarter. Tradewinds LLC.'s holdings in The Cigna Group were worth $251,000 at the end of the most recent reporting period.

Several other large investors have also recently made changes to their positions in CI. TCTC Holdings LLC bought a new position in The Cigna Group during the fourth quarter valued at $25,000. Collier Financial bought a new position in shares of The Cigna Group during the 4th quarter worth $32,000. ORG Wealth Partners LLC bought a new position in shares of The Cigna Group during the 4th quarter worth $34,000. Compagnie Lombard Odier SCmA purchased a new stake in The Cigna Group in the 4th quarter worth about $37,000. Finally, Heck Capital Advisors LLC bought a new stake in The Cigna Group in the 4th quarter valued at about $53,000. 86.99% of the stock is owned by hedge funds and other institutional investors.

Insider Activity at The Cigna Group

In related news, insider Noelle K. Eder sold 9,944 shares of the firm's stock in a transaction that occurred on Friday, March 7th. The shares were sold at an average price of $320.00, for a total value of $3,182,080.00. Following the sale, the insider now owns 13,406 shares in the company, valued at approximately $4,289,920. This trade represents a 42.59 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, insider Nicole S. Jones sold 4,904 shares of The Cigna Group stock in a transaction on Monday, March 3rd. The stock was sold at an average price of $308.12, for a total value of $1,511,020.48. Following the completion of the sale, the insider now directly owns 29,421 shares of the company's stock, valued at $9,065,198.52. The trade was a 14.29 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 43,751 shares of company stock valued at $13,603,991 in the last 90 days. Corporate insiders own 0.70% of the company's stock.

Remove Ads

The Cigna Group Trading Down 4.9 %

CI stock traded down $16.43 on Friday, reaching $322.02. The company's stock had a trading volume of 3,800,885 shares, compared to its average volume of 1,669,498. The business has a fifty day simple moving average of $308.72 and a two-hundred day simple moving average of $312.70. The firm has a market cap of $88.13 billion, a PE ratio of 26.31, a PEG ratio of 0.98 and a beta of 0.50. The company has a debt-to-equity ratio of 0.70, a quick ratio of 0.72 and a current ratio of 0.66. The Cigna Group has a 12-month low of $262.03 and a 12-month high of $370.83.

The Cigna Group (NYSE:CI - Get Free Report) last released its earnings results on Thursday, January 30th. The health services provider reported $6.64 EPS for the quarter, missing analysts' consensus estimates of $7.84 by ($1.20). The Cigna Group had a net margin of 1.39% and a return on equity of 18.61%. During the same period in the previous year, the firm posted $6.79 earnings per share. As a group, research analysts forecast that The Cigna Group will post 29.77 EPS for the current year.

The Cigna Group Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Thursday, March 20th. Stockholders of record on Wednesday, March 5th were issued a dividend of $1.51 per share. This represents a $6.04 annualized dividend and a dividend yield of 1.88%. This is a positive change from The Cigna Group's previous quarterly dividend of $1.40. The ex-dividend date was Wednesday, March 5th. The Cigna Group's dividend payout ratio (DPR) is presently 49.35%.

Analyst Upgrades and Downgrades

CI has been the subject of a number of research reports. Raymond James reiterated a "strong-buy" rating and set a $360.00 target price (down previously from $415.00) on shares of The Cigna Group in a research report on Friday, January 31st. Oppenheimer decreased their target price on shares of The Cigna Group from $400.00 to $375.00 and set an "outperform" rating on the stock in a report on Friday, January 31st. UBS Group lowered their price target on The Cigna Group from $410.00 to $390.00 and set a "buy" rating on the stock in a report on Monday, February 3rd. Royal Bank of Canada set a $355.00 price objective on shares of The Cigna Group in a research report on Friday, January 31st. Finally, Piper Sandler restated an "overweight" rating and issued a $348.00 target price (down previously from $394.00) on shares of The Cigna Group in a research report on Monday, February 3rd. Two equities research analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and three have given a strong buy rating to the company. Based on data from MarketBeat, The Cigna Group has an average rating of "Buy" and a consensus price target of $373.25.

The Cigna Group Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.